{{Rsnum
|rsid=16853834
|Gene=ATIC
|Chromosome=2
|position=215345513
|Orientation=plus
|GMAF=0.168
|Gene_s=ATIC
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 71.7 | 26.5 | 1.8
| HCB | 57.0 | 37.8 | 5.2
| JPT | 42.9 | 44.6 | 12.5
| YRI | 99.3 | 0.7 | 0.0
| ASW | 94.7 | 3.5 | 1.8
| CHB | 57.0 | 37.8 | 5.2
| CHD | 66.7 | 31.5 | 1.9
| GIH | 56.4 | 38.6 | 5.0
| LWK | 97.3 | 2.7 | 0.0
| MEX | 58.6 | 34.5 | 6.9
| MKK | 84.0 | 15.4 | 0.6
| TSI | 61.8 | 34.3 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=22461784
|Title=Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma
|OA=1
}}

{{PMID Auto
|PMID=17847007
|Title=Mutation in WNT10A is associated with an autosomal recessive ectodermal dysplasia: the odonto-onycho-dermal dysplasia.
|OA=1
}}

{{PMID Auto
|PMID=22450926
|Title=Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}